Combinations of leptin, adiponectin, resistin, and other inflammatory markers may enhance early detection of individuals at risk for AD, especially when integrated with neuroimaging and cognitive assessments [189,190]. This evidence concerns the gene ADIPOQ and Alzheimer disease.